The better CRO companies in China are Shanghai Medicilon Biomedical Co.
Medici is a professional biopharmaceutical preclinical integrated R & D services CRO, for the world's pharmaceutical companies and research institutions to provide a full range of domestic and international filing standards in line with the one-stop new drug R & D services. The company's services cover the entire process of pharmaceutical preclinical new drug research, mainly including drug discovery, pharmacological research and preclinical research.
Drug discovery R&D services include protein target validation, structural biology, chemical synthesis, compound activity screening and optimization; pharmaceutical research includes API and formulation process research, quality standards and stability studies; preclinical research includes pharmacodynamics, pharmacokinetics, toxicology and safety evaluation studies.
The company focuses on the needs of innovation and development of the global pharmaceutical industry, and based on the key link of innovative drug development, with the experience accumulated in serving the domestic and international biopharmaceutical industry, the company builds a comprehensive technology platform covering the key technologies of drug discovery, pharmaceutical research and preclinical research, and provides all-around preclinical research and development of new drugs for the global biopharmaceutical industry.
Introduction of CRO
CRO is known as Contract Research Organization (CRO) or Clinical Research Organization (CRO), which is simply an organization that receives commissioned research services from pharmaceutical or biotech companies. It provides professional services such as non-clinical and clinical trials, data analysis, and regulatory consulting for the development of new drugs.
The CRO system of professional division of labor has been implemented for a long time in foreign countries, providing pharmaceutical, biotechnology and medical device industries and research institutions with all the services from drug development to marketing, which can eliminate the need to invest too much manpower and equipment in certain phases of research and development, and at the same time track and analyze a large amount of clinical and preclinical test data to save the time of clinical trials. At present, there are more than 1,000 CROs in the world.
Reference: Shanghai Medicilon Bio-Pharmaceutical Co.